Hainan Huluwa Pharmaceutical Group Co., Ltd. announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced sales was CNY 308.485 million compared to CNY 258.725 million a year ago. Operating income was CNY 29.310 million compared to CNY 22.711 million a year ago. Net income was CNY 23.699 million compared to CNY 16.994 million a year ago. Basic earnings per share from continuing operations was CNY 0.06 compared to CNY 0.05 a year ago.